Microviable Therapeutics to sponsor Pharmabiotics 2021
Microviable Therapeutics is sponsoring Pharmabiotics Event 2021, a virtual conference taking place on April 28-29. […]
We are on TV
The TV show Conexión Asturias (RTPA) showcased Microviable Therapeutics activity in the microbiota field, currently focus on live biotherapeutic products (LBPs) development for Crohn´s disease and Autism Spectrum Disorder. […]
New member of the team: Rubén Díaz
Our R&D Director Noelia Martinez, PhD welcomes Rubén Díaz, Research Technician doing an internships in our microbiome team as part of his training for the Clinical and BioMedical Degree.
Claudio Hidalgo new CSO-CEO in Microviable Therapeutics
We are happy to welcome Claudio Hidalgo Cantabrana in our team as former CSO-CEO. […]
Job opportunity – Scientist – Microbiologist
Responsibilities: • Design and perform experiments […]
Job opportunity – PhD in Bioinformatics
Responsibilities: • Provide technical expertise in comparative genomics, microbiome data analysis and statistics. […]
Microviable Therapeutics attends Bio Europe 2019, the most important continental forum in the field of Biotechnology
Microviable Therapeutics and the Asturian biotechs Entrechem and Dreamgenics participate in the 25th edition of Bio Europe 2019 (Hamburg), the most important continental event in the field of life sciences and that contacts companies with [...]
Gut microbiota analysis for prevent COVID-19. Microviable Therapeutics
Gut microbiota analysis may help prevent the more serious effects of COVID-19. With this premise, Microviable seeks funding to design a predictive model and open the possibility of designing treatments from Spain. […]
Towards controlling the “second brain” that inhabits your intestines
View more at “La Voz de Asturias” Microviable Therapeutics offers the possibility of performing a microbiota transplant more comfortably and even storing the microbiota for future therapeutic uses. […]
Microviable Therapeutics participates in the ninth edition of Gut Microbiota For Health Summit (GMFH2020)
Microviable Therapeutics, through our CEO Rafael Martínez Permuy, was part of the “Gut Microbiota for Health World Summit” (#GMFH2020) that was held on March 7 and 8 in Madrid, a great international event on microbiota [...]